Exclusivereduction in PON activity has been described in different pathologies and conditionssuch as cardiovascular disease [18] andmetabolic syndrome [34], in which it isfrequent to detect low PON and unaltered ARE activities. This evidence concerns the gene PON1 and Down syndrome.